FloodLAMP COVID-19 Rapid Antigen Strip Tests - Comprehensive Report Comprehensive structured report on COVID-19 rapid antigen strip tests covering their technology relative to molecular testing, the EUA chronology from the first antigen authorization (May 2020) through 2024 multiplex home tests, serial screening regulatory evolution, federal COVIDTests.gov mail-to-home distribution volumes (900M+ to households), best-documented routine screening programs across municipal, school, healthcare, congregate, and first-responder settings, the Cochrane/IDSA performance review literature, Michael Mina's advocacy and the FDA policy shift, and 2024-2025 developments in multiplex testing, accessibility, and pandemic preparedness infrastructure. ai file regulatory fda-policy _AI_COVID-19 Rapid Antigen Strip Tests - Comprehensive Report.md regulatory/fda-policy/_AI_COVID-19 Rapid Antigen Strip Tests - Comprehensive Report.md 2026_04_01 Created by ChatGPT 5.4 Pro Extended during archive preparation. **NOT HUMAN VERIFIED - MAY CONTAIN ERRORS** Comprehensive report on COVID-19 rapid antigen strip tests covering technology, EUA timeline, serial screening authorization evolution, federal mail-to-home distribution, best-documented routine screening programs (San Francisco, Liverpool, schools, healthcare, workplaces), test performance review literature, Michael Mina's policy advocacy role, and 2024-2025 multiplex/preparedness developments. antigen-tests, rapid-tests, lateral-flow, EUA, serial-screening, home-testing, FDA-policy, preparedness md CC BY 4.0 - https://creativecommons.org/licenses/by/4.0/ 5866 10036 gfile-url xfile-github-download-url pdf-gdrive-url pdf-github-url github-markdown-url github-markdown-download-url web-pdf-url web-slides-url youtube-url web-url